Abstract

BackgroundMALDI-TOF MS is an analytical method that has recently become integral in the identification of microorganisms in clinical laboratories. It relies on databases that majorly employ pattern recognition or fingerprinting. Biomarker based databases have also been developed and there is optimism that these may be superior to pattern recognition based databases. This study compared the performance of ribosomal biomarker based MALDI-TOF MS and conventional methods in the identification of selected bacteria and yeast.MethodsThe study was a cross sectional study identifying clinically relevant bacteria and yeast isolated from varied clinical specimens submitted to a clinical laboratory. The identification of bacteria using conventional Vitek 2™ automated system, serotyping and MALDI-TOF MS was performed as per standard operating procedures. Comparison of sensitivities were then carried out using Pearson Chi-Square test and p-value of <0.05 was considered statistically significant. Secondary outcomes analyzed included the major and minor error rates.ResultsOf the 383 isolates MALDI-TOF MS and conventional methods identified 97.6 and 95.7% (p = 0.231) to the genus level and 97.4 and 88.0% (p = 0.000) to the species level respectively. Biomarker based MALDI-TOF MS was significantly superior to Vitek 2™ in the identification of Gram negative bacteria and Gram positive bacteria to the species level. For the Gram positive bacteria, significant difference was observed in the identification of Coagulase negative Staphylococci (p = 0.000) and Enterococcus (p = 0.008). Significant difference was also observed between serotyping and MALDI-TOF MS (p = 0.005) and this was attributed to the lack of identification of Shigella species by MALDI-TOF MS. There was no significant difference observed in the identification of yeast however some species of Candida were unidentified by MALDI-TOF MS.ConclusionBiomarker based MALDI-TOF MS had good performance in a clinical laboratory setting with high sensitivities in the identification of clinically relevant microorganisms.

Highlights

  • MALDI-TOF MS is an analytical method that has recently become integral in the identification of microorganisms in clinical laboratories

  • Matrix Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) is an analytical method developed in mid-1980s that has evolved rapidly to fingerprint spectra for various microorganisms including bacteria and fungi by analyzing protein profiles [1–5]

  • Databases were subsequently developed and adopted in clinical microbiology laboratories for the identification of clinically relevant microorganisms. These databases employ the concept of pattern recognition or fingerprinting where mass spectra obtained from a bacteria or yeast is compared to the existing spectra in the databases to find the closest match [6, 7]

Read more

Summary

Introduction

MALDI-TOF MS is an analytical method that has recently become integral in the identification of microorganisms in clinical laboratories. Databases were subsequently developed and adopted in clinical microbiology laboratories for the identification of clinically relevant microorganisms These databases employ the concept of pattern recognition or fingerprinting where mass spectra obtained from a bacteria or yeast is compared to the existing spectra in the databases to find the closest match [6, 7]. Ribosomal proteins have turned out to be one of the ideal biomarkers because they are abundant, highly conserved and encoded by chromosomal genes. They have molecular masses that fall within the 4 to 30 kDa range of MALDI-TOF MS [8]. Using ribosomal biomarkers Suarez et al were able to group various strains of Neisseria meningitidis into six subgroups that corresponded to sequence types and/or clonal complexes [9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call